ID

20418

Description

The Optimal Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent; ODM derived from: https://clinicaltrials.gov/show/NCT00418860

Link

https://clinicaltrials.gov/show/NCT00418860

Keywords

Versions (1)
  1. 2/22/17 2/22/17 -
Uploaded on

February 22, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Coronary Artery Disease NCT00418860

English

Eligibility Coronary Artery Disease NCT00418860

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with clinically significant de novo coronary artery disease
Description

Coronary Artery Disease de novo

Data type

boolean

Alias
UMLS CUI [1,1]
C1956346
UMLS CUI [1,2]
C1515568
stenting only with endeavor® stents
Description

Stenting | Stent marketed product

Data type

boolean

Alias
UMLS CUI [1]
C2348535
UMLS CUI [2,1]
C0038257
UMLS CUI [2,2]
C0683746
the sum of stent length is less than 60 mm for one lesion. the sum of stent length in multiple lesions does not matter.
Description

Length of stent | Lesion Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0449462
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C1265611
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
cardiogenic shock
Description

Shock, Cardiogenic

Data type

boolean

Alias
UMLS CUI [1]
C0036980
st-elevation myocardial infarction within 48 hours of symptom onset
Description

ST segment elevation myocardial infarction Time of symptom onset

Data type

boolean

Alias
UMLS CUI [1,1]
C1536220
UMLS CUI [1,2]
C1320528
prior implantation of drug-eluting stents
Description

Implantation Drug-Eluting Stent

Data type

boolean

Alias
UMLS CUI [1,1]
C0021107
UMLS CUI [1,2]
C1322815
left ventricular dysfunction (echocardiographic left ventricular ejection fraction < 25%)
Description

Ventricular Dysfunction, Left | echocardiography: left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0242698
UMLS CUI [2]
C2097013
stenting both branch of bifurcation lesion
Description

Stenting Bifurcation lesion Branch of artery Both

Data type

boolean

Alias
UMLS CUI [1,1]
C2348535
UMLS CUI [1,2]
C1299363
UMLS CUI [1,3]
C0500459
UMLS CUI [1,4]
C1706086
left main trunk lesion
Description

Lesion Left coronary artery main stem

Data type

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C0226031
graft vessels
Description

Graft Vessel

Data type

boolean

Alias
UMLS CUI [1,1]
C0332835
UMLS CUI [1,2]
C0005847
patients who have to receive clopidogrel due to other conditions
Description

clopidogrel Due to Other medical condition

Data type

boolean

Alias
UMLS CUI [1,1]
C0070166
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C3843040
patients who have to receive warfarin, cilostazol or other antiplatelet therapy
Description

Warfarin | cilostazol | Antiplatelet therapy

Data type

boolean

Alias
UMLS CUI [1]
C0043031
UMLS CUI [2]
C0055729
UMLS CUI [3]
C1096021
patient with chronic renal failure (s-cr > 2.0 mg/dl)
Description

Kidney Failure, Chronic | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2]
C0201976
hypersensitivity to clopidogrel or aspirin
Description

Hypersensitivity clopidogrel | Aspirin allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0070166
UMLS CUI [2]
C0004058
expectant survival less than 1 year
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
women who plan to become pregnant
Description

Pregnancy, Planned

Data type

boolean

Alias
UMLS CUI [1]
C0032992
patients with bleeding diathesis (coagulopathy, thrombocytopenia or platelet dysfunction, gastrointestinal or genitourinary bleeding within the prior 3 months)
Description

Bleeding tendency | Blood Coagulation Disorders | Thrombocytopenia | Platelet dysfunction | Gastrointestinal Hemorrhage | Hemorrhage Genitourinary

Data type

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
UMLS CUI [3]
C0040034
UMLS CUI [4]
C0679429
UMLS CUI [5]
C0017181
UMLS CUI [6,1]
C0019080
UMLS CUI [6,2]
C3887515
patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
Description

Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C2346570
Back to the top of the page

Similar models

Eligibility Coronary Artery Disease NCT00418860

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Coronary Artery Disease de novo
Item
patients with clinically significant de novo coronary artery disease
boolean
C1956346 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
Stenting | Stent marketed product
Item
stenting only with endeavor® stents
boolean
C2348535 (UMLS CUI [1])
C0038257 (UMLS CUI [2,1])
C0683746 (UMLS CUI [2,2])
Length of stent | Lesion Quantity
Item
the sum of stent length is less than 60 mm for one lesion. the sum of stent length in multiple lesions does not matter.
boolean
C0449462 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Shock, Cardiogenic
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI [1])
ST segment elevation myocardial infarction Time of symptom onset
Item
st-elevation myocardial infarction within 48 hours of symptom onset
boolean
C1536220 (UMLS CUI [1,1])
C1320528 (UMLS CUI [1,2])
Implantation Drug-Eluting Stent
Item
prior implantation of drug-eluting stents
boolean
C0021107 (UMLS CUI [1,1])
C1322815 (UMLS CUI [1,2])
Ventricular Dysfunction, Left | echocardiography: left ventricular ejection fraction
Item
left ventricular dysfunction (echocardiographic left ventricular ejection fraction < 25%)
boolean
C0242698 (UMLS CUI [1])
C2097013 (UMLS CUI [2])
Stenting Bifurcation lesion Branch of artery Both
Item
stenting both branch of bifurcation lesion
boolean
C2348535 (UMLS CUI [1,1])
C1299363 (UMLS CUI [1,2])
C0500459 (UMLS CUI [1,3])
C1706086 (UMLS CUI [1,4])
Lesion Left coronary artery main stem
Item
left main trunk lesion
boolean
C0221198 (UMLS CUI [1,1])
C0226031 (UMLS CUI [1,2])
Graft Vessel
Item
graft vessels
boolean
C0332835 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
clopidogrel Due to Other medical condition
Item
patients who have to receive clopidogrel due to other conditions
boolean
C0070166 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
Warfarin | cilostazol | Antiplatelet therapy
Item
patients who have to receive warfarin, cilostazol or other antiplatelet therapy
boolean
C0043031 (UMLS CUI [1])
C0055729 (UMLS CUI [2])
C1096021 (UMLS CUI [3])
Kidney Failure, Chronic | Creatinine measurement, serum
Item
patient with chronic renal failure (s-cr > 2.0 mg/dl)
boolean
C0022661 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Hypersensitivity clopidogrel | Aspirin allergy
Item
hypersensitivity to clopidogrel or aspirin
boolean
C0020517 (UMLS CUI [1,1])
C0070166 (UMLS CUI [1,2])
C0004058 (UMLS CUI [2])
Life Expectancy
Item
expectant survival less than 1 year
boolean
C0023671 (UMLS CUI [1])
Pregnancy, Planned
Item
women who plan to become pregnant
boolean
C0032992 (UMLS CUI [1])
Bleeding tendency | Blood Coagulation Disorders | Thrombocytopenia | Platelet dysfunction | Gastrointestinal Hemorrhage | Hemorrhage Genitourinary
Item
patients with bleeding diathesis (coagulopathy, thrombocytopenia or platelet dysfunction, gastrointestinal or genitourinary bleeding within the prior 3 months)
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0040034 (UMLS CUI [3])
C0679429 (UMLS CUI [4])
C0017181 (UMLS CUI [5])
C0019080 (UMLS CUI [6,1])
C3887515 (UMLS CUI [6,2])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device
Item
patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial